Less Ads, More Data, More Tools Register for FREE

Pin to quick picksICG Enterprise Trust Regulatory News (ICGT)

Share Price Information for ICG Enterprise Trust (ICGT)

Share Price is delayed by 15 minutes
Get Live Data
1,398.00    8.00 (0.58%)
Bid:
1,394.00
Ask:
1,412.00
Spread: 18.00 (1.291%)
Market Cap: £850.76m
ICGT Live PriceLast checked at - London Stock Exchange

Intraday ICG Enterprise Trust Share Chart

Interim Management Statement

19 May 2009 10:20

RNS Number : 4877S
Graphite Enterprise Trust PLC
19 May 2009
Β 

ο»Ώ

GRAPHITE ENTERPRISE TRUST PLC

INTERIM MANAGEMENT STATEMENT

QUARTER ENDED 31 MARCH 2009

Β 

Graphite Enterprise Trust PLCΒ ('Graphite Enterprise'Β or 'the Company')Β presents itsΒ InterimΒ  ManagementΒ  StatementΒ for the quarter ended 31Β MarchΒ 2009. ThisΒ isΒ the Company'sΒ firstΒ InterimΒ ManagementΒ Statement for the financial year ending 31 December 2009, as required by the UK Listing Authority's Disclosure and Transparency Rule 4.3.

Investment objective

The objective of Graphite Enterprise is to provide shareholders with long term capital growth through investment in unquoted companies, mostly through specialist funds but also directly.

Unaudited net asset value per shareΒ 

The unaudited net asset value per shareΒ as at 31Β March 2009Β wasΒ 429.1p. This represents aΒ fallΒ ofΒ 4.4%Β fromΒ the levelΒ atΒ 31 DecemberΒ 2008. TheΒ riseΒ in theΒ value of sterlingΒ againstΒ the euroΒ accounted for 3.2% of this movement and falls in underlying valuationsΒ accounted for the remaining 1.2%. Net income and expenses had a negligible effect.

Share priceΒ and discount

The share priceΒ fellΒ byΒ 11.0%Β to 166.5p in the periodΒ fromΒ 30 DecemberΒ to 31Β March.Β ThisΒ compares with a fall ofΒ 10.2% in the FTSE All-Share Index in the same period. The discountΒ toΒ theΒ net asset value per shareΒ increasedΒ from 58.4%Β toΒ 61.2%.

The share priceΒ hasΒ subsequentlyΒ risen strongly.Β Β Since the quarter end, the share price has increasedΒ by 66.4%Β toΒ 277.0p.Β This represents an increase ofΒ 48.1%Β in the year to date and compares with a rise of 2.5% in the Index in that period. The share priceΒ ofΒ 277.0pΒ representsΒ a discountΒ ofΒ 35.4%Β to theΒ net asset valueΒ per shareΒ at 31 March.

Valuations

The investment portfolio has been valued using the latest available managers' reports, withΒ 18.8% by value based onΒ valuationsΒ as at 31 March. The great majority of the remaining portfolio has been valued using managers' reports as at 31 December asΒ laterΒ reports have not yet been received. The provisionΒ of Β£18.5 millionΒ made against the portfolio at 31Β December 2008 has been maintained.

Based on these figures, the portfolio fell in value by 4.6% in the quarter to 31 March. Underlying valuations fell by 2.2% and the fall in the euroΒ accounted for the remaining 2.4% decline.

Cash flows

In the three months toΒ 31 MarchΒ 2009, the CompanyΒ funded drawdownsΒ of Β£4.8Β millionΒ andΒ the portfolio generated proceeds of Β£0.3 million.Β Other net cash out flowsΒ amounted toΒ Β£1.8 million. TheΒ riseΒ in theΒ value of sterling against theΒ euro in the quarter reducedΒ the sterling value ofΒ euro denominatedΒ cash balances by Β£5.7 million.Β Overall,Β cash balancesΒ fellΒ from Β£139.0 million to Β£127.0 million.

Β Β BalanceΒ sheetΒ and commitments

The summary balance sheet as at 31Β MarchΒ 2009Β is set out below:

Β 
Β£m
% of total assets
Total portfolio
187.8
59.3%
Cash and near cash
128.7
40.7%
Total assets
316.5
100.0%
Net asset value per share
429.1p
Β 

Β 

Outstanding commitments fell from Β£307.3 million to Β£293.0 million during the period. TheΒ effect of the rise in the value of sterling againstΒ the euro reduced the balance by Β£9.5 millionΒ in the quarter. Drawdowns accounted for the remaining Β£4.8 millionΒ of theΒ fall.Β No new commitments were made in the quarter. Overcommitment, the level by which commitments exceed cash and near cash, was Β£164.3 million at 31 March 2009.

In early April, the Company completedΒ aΒ secondaryΒ saleΒ whichΒ reduced the overcommitment level by Β£9.6 millionΒ withΒ no impact on net asset value. This would have had the effect of reducingΒ overcommitmentΒ toΒ Β£154.7 million, or 48.9% of net assets, at 31 March 2009.

Recent events

Other than the secondary sale noted above, theΒ Directors are not aware of anyΒ events or transactions which have taken place betweenΒ 31Β MarchΒ 2009Β and the date of publication of this statement which have had a material effect on the financial position of the company.Β 

This information has not been auditedΒ or reviewed by the Company's auditors.

Enquires:

Stephen Cavell

Tim Spence

0207 825 5300

This information is provided by RNS
The company news service from the London Stock Exchange
Β 
END
Β 
Β 
IMSMGGMKLLNGLZG
Date   Source Headline
31st Oct 20138:07 amRNSDisposal of Alexander Mann Solutions
25th Oct 20133:52 pmRNSNewsletter
3rd Oct 20132:48 pmRNSAnnouncement regarding Listing Rule 9.6.14
25th Sep 20134:45 pmRNSDirector/PDMR Shareholding
25th Sep 20137:00 amRNSHalf Yearly Report to 31 July 2013
8th Aug 201310:10 amRNSDisposal of Willowbrook Healthcare
5th Jul 20136:20 pmRNSNewsletter
3rd Jul 20139:56 amRNSHolding(s) in Company
26th Jun 20139:46 amRNSDirector/PDMR Shareholding
19th Jun 20132:51 pmRNSDirectorate Change
14th Jun 20133:18 pmRNSResult of AGM
13th Jun 20131:30 pmRNSInterim Management Statement
29th May 20131:24 pmRNSDisposal of Dominion Gas
13th May 20134:14 pmRNSDirector/PDMR Shareholding
18th Apr 20131:00 pmRNSAnnual Financial Report
17th Apr 201311:17 amRNSAnnouncement regarding Listing Rule 9.6.14
5th Apr 201312:58 pmRNSDirector/PDMR Shareholding
28th Mar 20137:02 amRNSUnaudited results for the year ended January 2013
27th Mar 20134:20 pmRNSAppointment of non-executive director
27th Mar 20134:14 pmRNSHolding(s) in Company
19th Dec 20125:01 pmRNSAudit committee appointment
6th Dec 20127:00 amRNSInterim Management Statement
26th Oct 20123:22 pmRNSAnnouncement in accordance with LR 9.6.14
5th Oct 201211:01 amRNSDisposal of NES Group
28th Sep 20127:00 amRNSHalf Yearly Report to 31 July
10th Jul 20123:47 pmRNSAudit committee appointment
22nd Jun 201212:18 pmRNSDirector/PDMR Shareholding
18th Jun 20124:11 pmRNSDirector/PDMR Shareholding
18th Jun 20127:00 amRNSDirector/PDMR Shareholding
14th Jun 20127:00 amRNSAGM Statement
11th Jun 20122:12 pmRNSInterim Management Statement 30 April 2012
28th May 201211:53 amRNSAnnual Information Update
9th May 20124:58 pmRNSAnnual Financial Report 31 Jan 2012
5th Apr 20127:00 amRNSFinal Results for the year ended 31 January 2012
27th Mar 20121:22 pmRNSAnnouncement re LR 9.6.13
30th Jan 201211:15 amRNSDirector/PDMR Shareholding
8th Dec 20117:00 amRNSInterim Management Statement
21st Nov 20111:03 pmRNSHolding(s) in Company
7th Oct 201111:58 amRNSIncrease in bank facility to £60 million
26th Sep 20117:00 amRNSHalf Yearly Report
22nd Jul 201112:14 pmRNSNOTIFICATION IN ACCORDANCE WITH LR 9.6.14
18th Jul 201111:30 amRNSDirector/PDMR Shareholding
14th Jul 20113:11 pmRNSDirectorate Change
24th Jun 20112:32 pmRNSDirector/PDMR Shareholding
16th Jun 20111:35 pmRNSAGM Statement 2011
15th Jun 201111:14 amRNSInterim Management Statement
2nd Jun 20112:04 pmRNSDisposal of Kurt Geiger
18th May 20115:24 pmRNSAnnual Information Update
19th Apr 20119:55 amRNSDirectorate update
18th Apr 20114:39 pmRNSAnnual Financial Report

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.